Bellevue Asset Management’s Vaxart VXRT Stock Holding History

Bellevue Asset Management’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-500	Closed	-$4K	–	625
2020 Q2	$4K	Buy	+500	New	+$1.44K	﹤0.01%	449

Other funds holding VXRT

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Asset Management's VXRT Position: Q3 2020 in Review

Bellevue Asset Management sold out of Vaxart (VXRT) in Q3 2020, closing a stake of 500 shares — an estimated $4K sold.

Bellevue Asset Management first reported a position in VXRT in Q2 2020 and held it in 1 quarter. The position peaked at $4K in Q2 2020. 130 funds tracked by Wall St. Rank hold VXRT as of Q3 2020.

Bellevue Asset Management reported no remaining Vaxart position as of Q3 2020 after selling out during the quarter.
Bellevue Asset Management sold 500 Vaxart shares in Q3 2020, an estimated $4K.
Bellevue Asset Management first reported a position in Vaxart in Q2 2020 and held it in 1 quarter.
Bellevue Asset Management's Vaxart position peaked at $4K in Q2 2020.
130 funds tracked by Wall St. Rank held Vaxart as of Q3 2020.

Based on Bellevue Asset Management's 13F filing for Q3 2020, filed 12 Nov 2020.